In focus · trending topic

ANDA

24 stories · following the connections

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

By Nasdaq OMXMay 30, 2017, 12:55 PM UTC

Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July

By Nasdaq OMXMay 25, 2017, 11:04 AM UTC